Di Giannatale et al. adopted AI-based radiomics to non-invasively characterize neuroblastoma tumours through the prediction of the CT-obtained MYCN amplification status, a marker linked to prognosis and tumour behaviour [83]. The gene discussed is MYCN; the disease is neoplasm.